Octávio Costa

Health Technology

Commercial Services

Consumer Services

Profile

Octávio Costa served as Chief Medical Officer at Cornerstone Pharmaceuticals, Inc. and Monopar Therapeutics, Inc. before earning a doctorate degree from Pontifícia Universidade Católica de São Paulo.

Former positions of Octávio Costa

Companies	Position	End
Cornerstone Pharmaceuticals, Inc. Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ.	Chief Tech/Sci/R&D Officer	-
MONOPAR THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Octávio Costa's experience

Training of Octávio Costa

Pontifícia Universidade Católica de São Paulo

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies